mCRPC

The systemic therapy options available for mCRPC – National Comprehensive Cancer Network

National Comprehensive Cancer Network (NCCN) shared a post on LinkedIn:

“Join us on April 28 for the Optimizing Patient Outcomes webinar on Metastatic Castration-Resistant Prostate Cancer: Systemic Therapy Updates.

Hiba Ahmad from the University of Colorado Cancer Center will summarize the systemic therapy options available for metastatic castration-resistant prostate cancer (mCRPC) and more.

Register now.”

The systemic therapy options available for mCRPC - National Comprehensive Cancer Network